Public Release: 29-May-2015 ONT-380 has stage IV HER2+ breast cancer patient 'worrying about normal stuff again' University of Colorado Denver Promising clinical trial results presented at the American Society for Clinical Oncology Annual Meeting 2015…

… anti-cancer agent ONT-380 against HER2+ breast cancer, in one case specifically against … survival of heavily pretreated HER2+ breast cancer patients. "I am thrilled … of the Breast Cancer Research Program and Young Women's Breast Cancer Translational …